E I D-Parry (India) Ltd
NSE:EIDPARRY
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
529.3
869.15
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
E I D-Parry (India) Ltd
E I D-Parry (India) Ltd
Revenue
E I D-Parry (India) Ltd
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
E I D-Parry (India) Ltd
NSE:EIDPARRY
|
Revenue
₹291.3B
|
CAGR 3-Years
16%
|
CAGR 5-Years
12%
|
CAGR 10-Years
9%
|
|
|
UPL Ltd
NSE:UPL
|
Revenue
₹432B
|
CAGR 3-Years
3%
|
CAGR 5-Years
11%
|
CAGR 10-Years
15%
|
|
|
Fertilisers And Chemicals Travancore Ltd
NSE:FACT
|
Revenue
₹50.5B
|
CAGR 3-Years
16%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
|
Bayer Cropscience Ltd
NSE:BAYERCROP
|
Revenue
₹51B
|
CAGR 3-Years
6%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
PI Industries Ltd
NSE:PIIND
|
Revenue
₹78.2B
|
CAGR 3-Years
18%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
|
Coromandel International Ltd
NSE:COROMANDEL
|
Revenue
₹215.4B
|
CAGR 3-Years
10%
|
CAGR 5-Years
11%
|
CAGR 10-Years
8%
|
|
E I D-Parry (India) Ltd
Glance View
E.I.D.-Parry (India) Ltd. engages in the manufacture and marketing of sugar. The company is headquartered in Chennai, Tamil Nadu and currently employs 2,068 full-time employees. - Parry (India) Limited is an India-based company, which is primarily engaged in the manufacturing of sugar and nutraceuticals. The firm has a presence in the farm inputs business, including bio-pesticides through its subsidiary, Coromandel International Limited. Its segments include Nutrient and allied business, Crop Protection, Sugar, Co-generation, Distillery, Nutraceuticals and Others. The company offers customized grades of pharmaceutical sugar to a range of pharma applications, such as tablet coatings, liquid orals, dry syrups, intravenous applications and in drug delivery systems. The company is a vendor to various specialty and industries, such as infant-food, beverages, and confectionary, among others. Its nutraceutical products include Organic Spirulina, Organic Chlorella and Organic Phycocyanin, among others. The company also offers hand sanitizer and medical grade hand sanitizer. The firm has approximately nine sugar plants, which are spread across South India.
See Also
What is E I D-Parry (India) Ltd's Revenue?
Revenue
291.3B
INR
Based on the financial report for Jun 30, 2024, E I D-Parry (India) Ltd's Revenue amounts to 291.3B INR.
What is E I D-Parry (India) Ltd's Revenue growth rate?
Revenue CAGR 10Y
9%
Over the last year, the Revenue growth was -17%. The average annual Revenue growth rates for E I D-Parry (India) Ltd have been 16% over the past three years , 12% over the past five years , and 9% over the past ten years .
You don't have any saved screeners yet
